POD-06.01 Mininvasive Open Tumor Enucleation (TE) vs. Percutaneous Radiofrequency Ablation (PRA) vs. Active Surveillance (AS) of Small Renal Masses <3 cm in Old Patients: Long-Term Results of a Prospective Follow-Up Study

Urology ◽  
2011 ◽  
Vol 78 (3) ◽  
pp. S20
Author(s):  
G. De Luca ◽  
M. Brausi ◽  
M. Gavioli ◽  
G. Verrini ◽  
G. Simonini ◽  
...  
2015 ◽  
Vol 13 (2) ◽  
pp. e87-e92 ◽  
Author(s):  
Riccardo Schiavina ◽  
Marco Borghesi ◽  
Hussam Dababneh ◽  
Lorenzo Bianchi ◽  
Barbara Longhi ◽  
...  

2014 ◽  
Vol 12 (3) ◽  
pp. 178-181 ◽  
Author(s):  
Eugenio Brunocilla ◽  
Marco Borghesi ◽  
Riccardo Schiavina ◽  
Livia Della Mora ◽  
Hussam Dababneh ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 1183 ◽  
Author(s):  
Giovanni Mauri ◽  
Francesco Alessandro Mistretta ◽  
Guido Bonomo ◽  
Nicola Camisassi ◽  
Andrea Conti ◽  
...  

Image-guided thermal ablations are increasingly applied in the treatment of renal cancers, under the guidance of ultrasound (US) or computed tomography (CT). Sometimes, multiple ablations are needed. The aim of the present study was to evaluate the long-term results in patients with renal mass treated with radiofrequency ablation (RFA) with both US and CT, with a focus on the multiple ablations rate. 149 patients (median age 67 years) underwent RFA from January 2008 to June 2015. Median tumor diameter was 25 mm (IQR 17–32 mm). Median follow-up was 54 months (IQR 44–68). 27 (18.1%) patients received multiple successful ablations, due to incomplete ablation (10 patients), local tumor progression (8 patients), distant tumor progression (4 patients) or multiple tumor foci (5 patients), with a primary and secondary technical efficacy of 100%. Complications occurred in 13 (8.7%) patients (6 grade A, 5 grade C, 2 grade D). 24 patients died during follow-up, all for causes unrelated to renal cancer. In conclusion, thermal ablations with the guidance of US and CT are safe and effective in the treatment of renal tumors in the long-term period, with a low rate of patients requiring multiple treatments over the course of their disease.


2013 ◽  
Vol 45 (2) ◽  
pp. 307-312 ◽  
Author(s):  
Eugenio Brunocilla ◽  
Marco Borghesi ◽  
Carlo Monti ◽  
Riccardo Schiavina ◽  
Giuseppe Martorana

1996 ◽  
Vol 253 (3) ◽  
pp. 158-166 ◽  
Author(s):  
J. Kiefer ◽  
V. Gall ◽  
C. Desloovere ◽  
R. Knecht ◽  
A. Mikowski ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document